₹500 Cr Loss: Pharma Cos in Indian Crisis
India's pharma sector is bracing for a ₹500 crore financial blow as the government bans 344 FDC drugs, including Corex and Phensedyl, impacting major companies' revenues and profitability.
Breaking News in English, Hindi & Telugu — AI Powered
India's pharma sector is bracing for a ₹500 crore financial blow as the government bans 344 FDC drugs, including Corex and Phensedyl, impacting major companies' revenues and profitability.